)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
bioAffinity Technologies
bioAffinity Technologies (BIAF) investor relations material
bioAffinity Technologies H.C. Wainwright 28th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H.C. Wainwright 28th Annual Global Investment Conference summary11 Sep, 2026
Conference overview
Over 500 companies from sectors like life sciences, technology, crypto, metals, mining, and energy participated in the event.
The event featured presentations from companies focused on innovative diagnostics and early cancer detection.
Market landscape and unmet needs
Lung cancer remains the leading cause of cancer deaths globally, with over 19 million at-risk Americans and 34 million at-risk individuals in the EU.
The global lung cancer diagnostic market is projected to reach $38 billion within eight years.
Early detection dramatically improves survival rates, with over 90% 10-year survival if caught at Stage 1A.
Product innovation and performance
CyPath Lung is a noninvasive, AI-driven test for early lung cancer detection, reimbursed by Medicare and most private insurers.
The test shows 92% sensitivity, 87% specificity, and 99% negative predictive value for small pulmonary nodules.
The technology profiles the lung microenvironment using sputum samples to distinguish cancer presence.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from bioAffinity Technologies
- Diagnostic company seeks capital via warrant-linked share offering amid ongoing losses and market risks.BIAF
Registration filing - AI-driven lung diagnostics firm offers 1.7M shares for resale; proceeds support working capital.BIAFRegistration filing
- Q2 2026 saw 216% CyPath® Lung test growth and 19% revenue increase, but liquidity risks remain.BIAFQ2 2026
- Common stock and pre-funded warrants offered via placement agent with standard protections.BIAFRegistration filing
- Noninvasive lung cancer diagnostic sees growth, but ongoing capital needs and risks remain.BIAFRegistration filing
- CyPath Lung streamlines nodule risk assessment, reducing unnecessary biopsies and patient anxiety.BIAFStatus update
- CyPath® Lung revenue surged, but losses widened and liquidity concerns remain.BIAFQ1 2026
- AI-powered lung diagnostics firm registers 497,483 shares for resale; proceeds depend on warrant exercises.BIAFRegistration filing
- AI-powered CyPath Lung enables accurate, noninvasive early lung cancer detection and market growth.BIAFInvestor presentation
Next bioAffinity Technologies earnings date
Q3 20266 Nov, 2026
bioAffinity Technologies
Next bioAffinity Technologies earnings date
Q3 20266 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage